知名学者引用


        除了所发表论文的被引用频次、期刊质量能够彰显学者的学术影响力以外,被知名学者引用也是一项学术评价的重要指标。
        当前同舟云学术认定的知名学者包括:诺贝尔奖、菲尔兹奖、图灵奖等奖项获得者,多个国家的院士,同舟云学术“2023全球学者学术影响力排行版”入榜的前10万学者等。

Ma, Dongjie 北京协和医学院医院被知名学者引用:54人次(黄金会员以上可以申请导出本人论文被全部知名学者引用的数据)

1. 杨明 中国 山东第一医科大学 Role of circular RNAs in cancer therapy resistance

2. Kazuhiro,Yasufuku 加拿大 University of Toronto Feasibility of computed tomography-derived surgical margin assessment in an ex vivo sublobar lung re..

3. Marcelo,Cypel 加拿大 University of Toronto Survival and pulmonary function in stage IA non-small cell lung cancer after sublobar resection vers..

4. 杨明 中国 山东第一医科大学 Circular RNAs in lung cancer: implications for preventing therapeutic resistance

5. Lerut, Toni 比利时 Katholieke Universiteit Leuven(KU Leuven) Robotic-assisted versus video-assisted lobectomy for resectable non-small-cell lung cancer: the RVlo..

6. Singhal, Sunil 美国 University of Pennsylvania Precision Oncology in Lung Cancer Surgery

7. Ronald J,Quinn 澳大利亚 GRIFFITH University Identification of Ligands for Ion Channels: TRPM2

8. Filippo,de Marinis 意大利 European Institute oncology Predictors, surrogate, and patient-reported outcomes in immunotherapy and salvage surgery for unrese..

9. Malcolm V,Brock 美国 JOHNS HOPKINS University Outcomes Comparison of Robot-Assisted and Video-Assisted Thoracoscopic Cardiac Sympathetic Denervati..

10. Primo N Jr,Lara 美国 University of California Davis Use of recombinant microRNAs as antimetabolites to inhibit human non-small cell lung cancer

11. Chen, Hong-Wu 美国 University of California DAVIS Use of recombinant microRNAs as antimetabolites to inhibit human non-small cell lung cancer

12. Ai-Ming,Yu 美国 University of California Davis Use of recombinant microRNAs as antimetabolites to inhibit human non-small cell lung cancer

13. Zatollah,Asemi 伊朗 Kashan University Medicine Science An epigenetic modulator with promising therapeutic impacts against gastrointestinal cancers: A mecha..

14. 李祥锴 中国 兰州大学 miR-22-3p Suppresses Cell Proliferation and Migration of Gastric Cancer by Targeting ENO1

15. Javad,Sharifi-Rad 伊朗 SHAHID BEHESHTI UNIVERSITY MEDICAL SCIENCES TRPM2-mediated Ca2+ signaling as a potential therapeutic target in cancer treatment: an u..

16. Cho, William Chi Shing 中国 香港大学 TRPM2-mediated Ca2+ signaling as a potential therapeutic target in cancer treatment: an u..

17. Hiroaki,Saito 日本 TOTTORI University Impact of Robot-Assisted Minimally Invasive Esophagectomy for Esophageal Cancer: A Propensity Score-..

18. Marco,Boscaro 意大利 University of PADUA Dynamic Testing for Differential Diagnosis of ACTH-Dependent Cushing Syndrome: A Systematic Review a..

19. Maria,Fleseriu 美国 Oregon Health and Science University Dynamic Testing for Differential Diagnosis of ACTH-Dependent Cushing Syndrome: A Systematic Review a..

20. Saeed,Samarghandian 伊朗 Neyshabur University Medicine Science The pharmacological and biological importance of EZH2 signaling in lung cancer

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3